Killer Cell Immunotherapy Offers Potential Cure for Advanced Pancreatic Cancer
Drug Could Cut Transplant Rejection
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London (QMUL). In the study, funded by the British Heart Foundation (BHF) and published in Immunity, researchers found that the enzyme glucokinase increases the movement of…
Antidote To Synthetic Cannabis ‘Spice’ Intoxication Could Be Found In Slimming Drug
Early research from Queen Mary University of London has potentially found an antidote that can rapidly stop the intoxicating effects of cannabis and synthetic cannabinoids. Synthetic cannabinoids, such as ‘Spice’ and ‘Black Mamba’, are becoming an increasing problem, especially with youths game to experiment and within the homeless and prison populations, due to their cheapness…
Over 100 New Blood Pressure Genes Could Provide Targets for Treating Hypertension
Scientists have found 107 new gene regions associated with high blood pressure, potentially enabling doctors to identify at-risk patients and target treatments. The study, led by Queen Mary University of London (QMUL) and Imperial College London, suggests that by using genetic testing, doctors could target medication to certain high blood pressure (hypertension) patients and advise…